학술논문
Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial
Document Type
Article
Author
Prat, A.; Saura, C.; Pascual, T.; Muñoz, M.; Paré, L.; Chic, N.; González Farré, X.; Oliveira, M.; Céliz, P.; Ciruelos, E.; Villagrasa, P.; Gavilá, J.; González Farré, B.; Galván, P.; Arumi, M.; Hernando, C.; Fernández, P.L.; Gil-Gil, M.; Ferrer, N.; Montaño, A.; Izarzugaza, Y.; Llombart-Cussac, A.; Bratos, R.; González Santiago, S.; Martínez, E.; Hoyos, S.; Rojas, B.; Virizuela, J.A.; Ortega, V.; López, R.
Source
In: The Lancet Oncology . (The Lancet Oncology, January 2020, 21(1):33-43)
Subject
Language
English
ISSN
14745488
14702045
14702045